Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci Sells 1,858 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 1,858 shares of Tempus AI stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $67.57, for a total value of $125,545.06. Following the transaction, the chief accounting officer now owns 55,379 shares of the company’s stock, valued at $3,741,959.03. The trade was a 3.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Tempus AI Trading Up 6.1 %

Shares of TEM opened at $68.96 on Friday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The company’s fifty day moving average is $44.36 and its two-hundred day moving average is $48.84. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $79.49.

Hedge Funds Weigh In On Tempus AI

A number of large investors have recently modified their holdings of TEM. ARK Investment Management LLC grew its holdings in shares of Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after purchasing an additional 3,141,487 shares during the period. NEA Management Company LLC raised its stake in shares of Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after purchasing an additional 813,169 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its stake in Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of Tempus AI by 1.0% during the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock valued at $45,920,000 after purchasing an additional 8,387 shares during the last quarter. Finally, Millennium Management LLC bought a new stake in Tempus AI in the 2nd quarter valued at about $8,067,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have weighed in on TEM shares. Piper Sandler restated a “neutral” rating and issued a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Wolfe Research assumed coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 target price for the company. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the company from $45.00 to $65.00 in a report on Monday, November 11th. Bank of America upped their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Finally, Needham & Company LLC restated a “buy” rating and issued a $56.00 target price on shares of Tempus AI in a report on Tuesday, January 14th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and an average target price of $58.55.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.